← Mechanisms of action
CLDN18
SINGLE PROTEINHomo sapiens
Preferred name: Claudin-18 ChEMBL ↗
Linked proteins
Drugs acting on this target (72)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| cpo102 | Adcc | experimental | mAb | CLDN18 adcc |
| fl-301 | Adcc | experimental | mAb | CLDN18 adcc |
| lm-102 | Adcc | experimental | mAb | CLDN18 adcc |
| lm-302 | Adcc | experimental | mAb | CLDN18 adcc |
| mil93 | Adcc | experimental | mAb | CLDN18 adcc |
| ibi 389 | Antagonist | experimental | mAb | CLDN18 antagonist |
| js012 | Antagonist | experimental | Small molecule | CLDN18 antagonist |
| pt886 | Antagonist | experimental | mAb | CLDN18 antagonist |
| q-1802 | Antagonist | experimental | mAb | CLDN18 antagonist |
| tj033721 | Antagonist | experimental | mAb | CLDN18 antagonist |
| 89zr-ny005 | Binding agent | experimental | mAb | CLDN18 binding agent |
| AMG-910 | Binding agent | experimental | mAb | CLDN18 binding agent |
| asp2138 | Binding agent | experimental | mAb | CLDN18 binding agent |
| atg-022 | Binding agent | experimental | mAb | CLDN18 binding agent |
| azd5863 | Binding agent | experimental | mAb | CLDN18 binding agent |
| claudiximab | Binding agent | experimental | mAb | CLDN18 binding agent |
| cmg901 | Binding agent | experimental | mAb | CLDN18 binding agent |
| qls31905 | Binding agent | experimental | mAb | CLDN18 binding agent |
| rc118 | Binding agent | experimental | mAb | CLDN18 binding agent |
| skb315 | Binding agent | experimental | mAb | CLDN18 binding agent |
| sot102 | Binding agent | experimental | mAb | CLDN18 |
| sysa1801 | Binding agent | experimental | mAb | CLDN18 binding agent |
| tac01-cldn18.2 | Immunity, active | experimental | Cell therapy | CLDN18 immunity, active |
| amg 910 | Immunity, passive | experimental | mAb | CLDN18 immunity, passive |
| azd0901 | Immunity, passive | experimental | mAb | CLDN18 immunity, passive |
| azd6422 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| car-cldn18.2 t-cells | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| car-nk182 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| cbg131 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| ct041 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| ct048 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| ctb | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| dual-targeting cldn18.2 and pd-l1 car-t cells | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| hec-016 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| ibi343 | Immunity, passive | experimental | mAb | CLDN18 immunity, passive |
| ibi345 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| kd-496 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| ksh01 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| lb1908 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| lcar-c182a | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| lcar-c18s cells | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| ly011 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| nbl-015 | Immunity, passive | experimental | mAb | CLDN18 immunity, passive |
| tils and car-tils targeting her2, mesothelin, psca, muc1, lewis-y, gpc3, axl, egfr, claudin18.2/6, ror1, gd1, or b7-h3 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| xkdct225 | Immunity, passive | experimental | Cell therapy | CLDN18 immunity, passive |
| ab011 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| ak132 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| ale.c04 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| ale.f02 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| askb589 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| azd4360 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| ba1301 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| bl-m05d1 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| claudiximab | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| da-3501 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| dr30303 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| eo-3021 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| ibi 360 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| imc008 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| js107 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| lb4330 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| lnf2007 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| pm1032 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| qls7305 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| sg1906 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| sibp-a18 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| torl-3-600 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| tqb2103 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| tst001 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| xnw27011 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| zl-1211 | Inhibitor | experimental | mAb | CLDN18 inhibitor |
| zolbetuximab (Vyloy) | Inhibitor | approved | mAb | CLDN18 inhibitor |